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Golgins are a family of Golgi-localized long coiled-coil proteins. The major golgin function
is thought to be the tethering of vesicles, membranes, and cytoskeletal elements to the
Golgi. We previously showed that knockdown of one of the longest golgins, Giantin,
altered the glycosylation patterns of cell surfaces and the kinetics of cargo transport,
suggesting that Giantin maintains correct glycosylation through slowing down transport
within the Golgi. Giantin knockdown also altered the sizes and numbers of mini Golgi
stacks generated by microtubule de-polymerization, suggesting that it maintains the
independence of individual Golgi stacks. Therefore, it is presumed that Golgi stacks lose
their independence following Giantin knockdown, allowing easier and possibly increased
transport among stacks and abnormal glycosylation. To gain structural insights into
the independence of Golgi stacks, we herein performed electron tomography and 3D
modeling of Golgi stacks in Giantin knockdown cells. Compared with control cells,
Giantin-knockdown cells had fewer and smaller fenestrae within each cisterna. This
was supported by data showing that the diffusion rate of Golgi membrane proteins is
faster in Giantin-knockdown Golgi, indicating that Giantin knockdown structurally and
functionally increases connectivity among Golgi cisternae and stacks. This increased
connectivity suggests that contrary to the cis-golgin tether model, Giantin instead
inhibits the tether and fusion of nearby Golgi cisternae and stacks, resulting in transport
difficulties between stacks that may enable the correct glycosylation of proteins and
lipids passing through the Golgi.
Keywords: Golgi, golgins, glycosylation, endoplasmic reticulum, electron tomography
INTRODUCTION
Eukaryotic cells have various forms of glycans on their cell surfaces that are important for cell–cell
communications, development, differentiation, infection, and signaling. Most of these glycans are
attached to lipids and proteins initially in the endoplasmic reticulum (ER) and are further extended
and trimmed in the Golgi apparatus.
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Glycan structures vary depending on cell types and species.
One of the reasons for such structural variation is differences in
the expression patterns of glycosyltransferases and glycosidases
responsible for glycan biosynthesis, although it may also depend
on the structure of the Golgi (Koreishi et al., 2013a; Xiang et al.,
2013). The Golgi apparatus is usually a pancake-like structure
consisting of a stack of several flat membrane cisternae, which is
further linked laterally and forms a ribbon-like structure [Golgi
ribbon (Wei and Seemann, 2010; Gosavi and Gleeson, 2017)].
The stacking of Golgi cisternae is secured by Golgi stacking
proteins GRASP55/65, and their loss disrupts Golgi stacking and
accelerates cargo transport without affecting the lateral linking
(ribbon formation) of the stacks (Xiang et al., 2013). Glycan
analyses showed that the loss of GRASP55/65 decreased the cell
surface expression of high-mannose- and complex-type glycans,
which are formed in the Golgi (Xiang et al., 2013). The authors of
this study proposed that GRASP55/65 may slow cargo transport
down to ensure correct glycosylation occurs through the Golgi by
maintaining Golgi stacks in normal cells (Xiang et al., 2013).
Similar to this study, we previously reported that loss of
Giantin, the longest golgin which is a family of Golgi-localized
coiled-coil proteins, also accelerates cargo transport by affecting
lateral linking of the stacks (Koreishi et al., 2013a). Lectin staining
showed that the loss of Giantin increased the proportion of highly
branched glycans with sialic acids, representing complex-type
glycans (Koreishi et al., 2013a). The key difference between our
finding and that of Xiang et al. with regard to glycan structures is
whether lateral stack linking is also affected.
Giantin, also known as GCP364, was originally identified as
a C-terminally anchored Golgi membrane protein (Linstedt and
Hauri, 1993; Linstedt et al., 1995; Toki et al., 1997). It is also
recognized as an autoantigen in autoimmune diseases (reviews
Stinton et al., 2004; Saraste, 2016). Golgins share predicted coiled-
coil structures known to form long rod-like structures, which
function in tethering vesicles, membranes, and other cytoskeletal
factors. Giantin is thought to tether coatomer protein I (COPI)-
coated vesicles to cis-Golgi membranes (Sönnichsen et al., 1998;
Lesa et al., 2000; Linstedt et al., 2000; Shorter and Warren, 2002,
the cis-golgin tether model). In this model, Giantin on COPI
vesicles and golgin GM130 in cis-Golgi membranes are linked by
a soluble protein, p115; therefore, COPI vesicles are tethered to
cis-Golgi. Although Giantin localizes to both the Golgi and COPI
vesicles, it is distributed asymmetrically, with more seen in COPI
vesicles (Sönnichsen et al., 1998).
To understand the cis-golgin tether model, we previously
performed RNA interference (RNAi) of Giantin. Without the
tether, it was presumed that cells would be filled with untethered
vesicles that may cause incorrect vesicle transport. Anterograde
transport was accelerated and sialic acid-bearing cell surface
glycans were increased by the loss of Giantin. However, we
observed surprisingly few vesicles, which were likely untethered
vesicles. This suggested that Giantin has other functions than
the COPI vesicle tether. Indeed, we detected an alteration of
lateral linking of the stacks following the loss of Giantin (Koreishi
et al., 2013a). To gain insights into the structural alteration,
which may have caused transport alteration, we herein performed
3D modeling of Golgi cisternae and stacks, and found them to
be tightly linked laterally by Giantin depletion. This finding is
supported by the observed increased lateral diffusion of Golgi
membrane proteins.
MATERIALS AND METHODS
Cell Lines, Culture, Small Interfering
(si)RNA Transfection, and Fluorescence
Recovery After Photobleaching (FRAP)
Experiments
HeLa cells (CCL-2, ATCC, Manassas, VA) were maintained
and transfected with Giantin siRNA as described previously
(Koreishi et al., 2013a). HeLa cells stably expressing murine
Golgi mannosidase II (ManII)-GFP (a gift from J. White,
European Molecular Biology Laboratory, Heidelberg, Germany)
were established as previously described (Maday et al., 2008;
Koreishi et al., 2013b). FRAP experiments were performed as
described in earlier studies (Rutz et al., 2009; Koreishi et al.,
2013b). The relative diffusion rate and % maximum recovery
were obtained by fitting the FRAP data to Ellenberg’s diffusion
equation (Ellenberg et al., 1997) shown as below.
%FRAP = (%maximum recovery) ∗ (1−√((diffusion rate)/
((diffusion rate)+ pi ∗ (time after recovery))))
Conventional Electron Microscopy
Conventional electron microscopy was performed as
previously described (Hayashi-Nishino et al., 2009) with slight
modifications. In brief, cells were fixed in 2.5% glutaraldehyde in
0.1 M sodium phosphate buffer, pH 7.4 (PB) for 1 h. Cells were
washed in PB, then scraped and collected as pellets. These were
post-fixed in buffer containing 1% OsO4 and 0.5% potassium
ferrocyanide, dehydrated in a series of graded ethanol solutions,
followed by propylene oxide, and embedded in epoxy resin.
Electron Tomography
Cell specimens prepared as above were cut into 300-nm thick
sections, collected on formvar/carbon-coated grids, stained with
uranyl acetate and lead citrate, and examined using a JEM-
2100 transmission electron microscope (The Japan Electron
Optics Laboratory Co., Ltd. (JEOL; Tokyo, Japan) at accelerating
voltages of 200 kV. Tilt series data for each section were recorded
around two orthogonal axes (1◦ interval over ± 60◦ for each
axis) using a 2k × 2k CCD camera (Gatan US1000, Gatan Inc.,
Warrendale, PA). Tomograms were computed and joined to
form a dual-axis tomogram using the IMOD software package.
Subcellular structures within the 3D volume were segmented,
and their surfaces were modeled with IMOD (Kremer et al.,
1996; Mastronarde, 1997). Contours of membranes of the Golgi
apparatus and other membrane structures visible at the Golgi
regions were traced manually to generate the final models.
Vesicles were represented by spheres.
Cell Cycle Analysis
Cell cycle analysis was performed as described (Liu et al., 2017).
Briefly, HeLa cells with or without Giantin RNAi were treated
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with trypsin-EDTA and fixed with ice-cold 70% ethanol
overnight at –20◦C. After washing with phosphate-buffered
saline, cells were stained with 0.1 mg/ml propidium iodide
(Thermo Fisher Scientific, Waltham, MA, United States)
containing 0.1 mg/ml RNase A for 30 min. DNA contents
in stained cells were measured by a Tali image-based
cytometer (Thermo Fisher Scientific) or a BD Accuri C6
flow cytometer (Becton, Dickinson and Company, Franklin
Lakes, NJ, United States).
RNA Isolation and Quantitative (q)PCR
Total RNA was isolated using the Total RNA Extraction Kit
(Viogene, New Taipei City, Taiwan) and reverse-transcribed
using the SuperScript VILO cDNA Synthesis Kit (Thermo
Fisher Scientific). Alternatively, total RNA extraction and
reverse transcription were performed using the SuperPrep R©
Cell Lysis & RT Kit for qPCR (Toyobo, Tokyo, Japan).
The relative expression of mRNAs was quantified using the
LightCycler R© 480 with SYBR Green I Master (Indianapolis,
IN). Primer sets used were as follows: human beta-actin fwd:
5′-CCAACCGCGAGAAGATGA-3′ and human beta-actin rev:
5′-TCCATCACGATGCCAGTG-3′; human GALNT5 fwd: 5′-
AGAGCCATTGAAGACACCAGA-3′ and human GALNT5rev:
5′-CACTGGTGGTTGGGAGGTTA-3′; human GALNT5
fwd2: 5′-CCAGTGGATAGAGCCATTGAA-3′ and human
GALNT5 rev2: 5′-TGGTTGGGAGGTTATTGTGAA-3′; human
ST6GALNAC3 fwd: 5′-CACAGAGAAGCGCATGAGTTA-3′
and human STGALNAC3 rev: 5′-TCTTCAAGGCGTGAACA
AAA-3′; human EXTL1 fwd: 5′-TGTGAGCAAGACCCTGGAC-
3′ and human EXTL1 rev: 5′-CCAGAGATGAGGCAGAAGGT-
3′; and human ST6GAL2 fwd: 5′-TCATCCTAAATTTATA
TGGCAGCTC-3′ and human ST6GAL2 rev: 5′-TGAGGA
TGCCCAAGCAGT-3′.
Statistical Analysis
All statistical comparisons in this study were performed using the
Student’s t-test for independent samples or a non-parametric test,
Mann-Whitney U Test calculated by an online calculator: https:
//www.socscistatistics.com/tests/mannwhitney.
RESULTS
Loss of Giantin Elongates Golgi
Cisternae
In many mammalian cells, Golgi stacks are connected as
ribbon-like structures that are dependent on the integrity of
microtubules, the depolymerization of which by Nocodazole
disperses the ribbon-like Golgi into mini Golgi stacks that can
be observed by light microscopy. Our previous work using
Nocodazole suggested that the connectivity between Golgi stacks
may be altered by the loss of Giantin (Koreishi et al., 2013a).
To gain insights into these changes associated with the loss
of Giantin, we performed conventional electron microscopy of
Giantin siRNA-treated and control cells (Figure 1A). All the
efficiencies of Giantin knockdown shown in this study were
FIGURE 1 | Loss of Giantin elongates Golgi cisternae. (A) Typical electron
micrographs of Golgi cisternae in Giantin and control siRNA-treated cells. Bar,
500 nm. (B) Cisternal lengths were measured by tracing the cisternae
manually using ImageJ software (B, n = 10 micrographs, bar, SEM,
P < 0.00001).
>90% as estimated by immunofluorescence (Supplementary
Figure S1). Compared with control cells, Giantin siRNA-treated
cells had Golgi cisternae that were around 1.5 times longer
(Figure 1B). Supplementary Figure S2 depicts the distribution
of the cisternal lengths as a histogram. Because there was
no significant change in the numbers of Golgi cisternae per
stack following Giantin RNAi (Supplementary Figure S3), the
observed elongation is likely the result of lateral fusions of
Golgi cisternae rather than increased membranes in Golgi areas.
Importantly, other siRNA to Giantin (siRNA5) also had the
similar effect on cisternal lengths, and exogenous expression of
rat Giantin, which is resistant to siRNAs used, reduced the effect
partly (Supplementary Figure S4).
Loss of Giantin Connects or Fuses Golgi
Cisternae and Stacks
To investigate the lateral fusion of Golgi cisternae in living cells,
we performed FRAP of the Golgi membrane protein ManII-GFP
(Storrie et al., 1998; Ward et al., 2001). As shown in Figure 2,
FRAP of ManII-GFP in Giantin siRNA-treated cells was much
faster than that in control cells. The FRAP data were curve-
fitted to Ellenberg’s diffusion equation revealing that the relative
diffusion rate of ManII-GFP in Giantin-siRNA-treated Golgi was
2.3-fold compared to the control. These data suggested that Golgi
proteins in Giantin siRNA-treated Golgi move faster and more
readily than in control cells, indicating that the connectivity
between Golgi cisternae and stacks was functionally increased
by the loss of Giantin. Importantly, other siRNA to Giantin
(siRNA5) also had the similar effect on FRAP, and exogenous
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FIGURE 2 | Loss of Giantin changes the intra-connectivity between Golgi
cisternae/stacks. HeLa cells stably expressing ManII-GFP with Giantin or
control siRNA treatment were subjected to FRAP experiments. GFP-labeled
Golgi in ManII-GFP expressing cells was photobleached, and fluorescence
recoveries were monitored for 200 s and graphed (n = 10, bar, SD).
Representative images of fluorescence recovery at the indicated time points
are shown below. Sizes 25.5 (w) × 25.5 (h) µm. The circles represent the
bleached area.
expression of rat Giantin, which is resistant to siRNAs used,
reduced the effect partly (Supplementary Table S1).
For further structural analysis, we carried out 3D modeling
of electron tomograms of Golgi cisternae/stacks following the
loss of Giantin. Approximately 10 tomograms were used for
3D modeling by IMOD software for 3D reconstruction of
EM serial sections. Compared with Golgi cisternae of control
cells, those of Giantin siRNA-treated cells were much smoother
with fewer and smaller wells [Rambourg and Clermont (1990)
and fenestrae which were previously defined as “non-compact
regions” (Ladinsky et al., 1999; Figure 3A)]. Of note, one of the
tomographic slices used in 3D modeling shown in the top panels
of Figure 3A reveals longer cisternae in Giantin siRNA-treated
cells than those in control cells. This is in a good agreement with
Figure 1A. Examples of tomograms and modeling are shown in
Supplementary Movies and Supplementary Figure S5.
The smoothness of the cisternae was then quantified by
comparing the volumes of 3D models without fenestrae to
with fenestrae (Figure 3B). In this quantification, the difference
between cisternal volumes of the actual model and those of
the no-fenestra model indicates the volumes of fenestrae. An
example of the no-fenestra model is shown in Supplementary
Figure S6. The volume differences, i.e., the volume of the
FIGURE 3 | Loss of Giantin fuses Golgi cisternae. (A) Typical 3D models of
Golgi cisternae in Giantin and control siRNA-treated cells. One of the
tomographic slices used for these 3D models is shown in top panels. Note
that the Golgi cisternae visible in RNAi cells appear longer than those in
control cells. Bar, 500 nm. Arrows indicate large fenestrae in cisternae. The
cis-most and trans-most cisternae are labeled C1 and C5, respectively.
(B) The reduction of cisternal volumes from the corresponding no-fenestra
model is shown as the % volume reduction in Giantin and control
siRNA-treated cells. Bar, SD (n = 4, ∗P < 0.005).
fenestrae, in control cells depended on the positions of the
cisternae (C2–C3), but were approximately 20∼30%. In contrast,
the differences in Giantin siRNA-treated cells were less than
10%, which is indicative of smoother cisternae. We found no
significant difference in C1 and C4 cisternae because of their
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heterogeneity. We also tried to quantify the smoothness by
comparing surface areas to volumes. If the structure has a
rough surface, the ratio between the surface area and volume
would be higher than if the structure was smooth. However,
because cisternae appeared to be thicker near the fenestrae
(Supplementary Figure S7), we concluded that quantification
of smoothness in this way is not appropriate (data not shown).
The total volumes (including those of un-modeled fenestrae) of
C2 cisternae are 0.011 ± 0.006 µm3 and 0.0097 ± 0.003 µm3
for control and RNAi cells, respectively. Importantly, the loss of
Giantin did not change cell cycle progression (data not shown).
DISCUSSION
Our previous data suggested that the Golgi stack loses its
independence of individual Golgi stacks following Giantin
knockdown, allowing easier transport among Golgi stacks that
may be responsible for increased transport and abnormal
glycosylation (Koreishi et al., 2013a). In this study, we confirmed
by 3D modeling of electron tomograms that Golgi stacks and
cisternae have less independence after the loss of Giantin.
Giantin has a proposed function as a cis-Golgin tether which
tethers COPI vesicles to cis-Golgi membranes (Sönnichsen et al.,
1998; Linstedt et al., 2000; Alvarez et al., 2001). In the present
study, we modeled vesicles around Golgi stacks but were unable
to see more untethered COPI vesicles after the loss of Giantin
(Supplementary Figure S8). To test whether the loss of Giantin
increases untethered COPI vesicles, we may need to use larger
specimens for future modeling.
Golgi 3D Structures
3D Golgi modeling has previously revealed novel Golgi structures
including connected Golgi cisternae, branched Golgi cisternae,
and autophagosome-like Golgi (reviews Mogelsvang et al., 2004;
Marsh, 2005; Martínez-Alonso et al., 2013). Among these works,
the first and most crucial examination was 3D modeling of
the Golgi in normal rat kidney cells (Ladinsky et al., 1999).
Importantly, this work quantitatively described non-compact
regions that include unconnected cisternae, some vesicles, and
fenestrae. We also identified this “non-compact region” between
Golgi stacks in HeLa cells in the present study, although few
vesicles were observed in this region.
Our comparison of cisternal volumes between actual and no-
fenestra models revealed a relative volume of the non-compact
region in control HeLa cells of around 20% (Figure 3). This
volume was reduced by the loss of Giantin, suggesting that
Giantin plays an essential role in the generation of the non-
compact region although the function of this region remains
unclear. Extrapolating from our previous work showing that the
loss of Giantin increases cargo transport and affects cell surface
glycans, we speculate that the non-compact region organizes
transport through the Golgi. Further, our previous work by
2D immuno-EM showed that Giantin localizes to the rims of
Golgi cisternae that may be part of the fenestrae/non-compact
regions. It is noteworthy that depletion of the Golgi-localized
small GTPase Rab6 increased the lateral continuity of the Golgi
(Storrie et al., 2012), and Rab6 was also shown to interact
with Giantin (Rosing et al., 2007). Taken together, Giantin may
function together with Rab6 in the maintenance of the non-
compact region. Another possibility is that the loss of Giantin
reduces fission of the Golgi cisternae or changes in the flux of
vesicle transport within the Golgi. Although we are unable to test
this possibility, the loss of Giantin did not increase the number
of vesicles in the areas observed (Supplementary Figure S8),
suggesting that these may be comparable with or without Giantin.
Our previous work showed that the loss of Giantin
altered lateral connectivity of Golgi stacks using microtubule
depolymerizer, Nocodazole. Although this appeared to contradict
the present study, the previous study, in particular, the EM
study was done in the presence of Nocodazole suggesting
that microtubules may contribute to the Giantin-regulated
lateral connectivity. From this viewpoint, the Golgi-microtubule
associate proteins (GMAPs) together with Giantin may also play
a key role in the independence of Golgi cisternae, but we have
not identified such GMAPs, yet. Our updated working model is
shown in Supplementary Figure S10.
Giantin and Glycosylation
Our previous data showed that the loss of Giantin altered
the glycosylation patterns of cell surface proteins (Koreishi
et al., 2013a). Golgins, including Giantin, have been shown
to interact with some glycosyltransferases and are required
for their targeting to functional sites (Petrosyan et al., 2012).
These golgin-interacting glycosyltransferases are responsible for
the biosynthesis of mucin-type glycoproteins. We did not
test whether the localization of these enzymes or the surface
expression of mucin-type glycoproteins is changed after the loss
of Giantin, but the observed alterations in glycosylation patterns
might reflect the targeting failure of glycosyltransferases.
Another study showed that loss of Giantin by
clustered regularly interspaced short palindromic
repeats (CRISPR)/CRISPR-associated protein 9 affected
glycosyltransferase expression levels in the RPE-1 cell line
derived from human retina (Stevenson et al., 2017). We also
tested those glycosyltransferase expression levels in HeLa
cells after Giantin RNAi, but found no significant changes
(Supplementary Figure S9). The authors also claimed that
the knock-out of Giantin by CRISPR in RPE1 cells did not
change the cisternal lengths and cargo transport. Therefore, the
phenotypes in cisternal lengths, glycosylation, and transport that
we observed by the knock-down of Giantin with siRNAs can be
specific to HeLa cells.
Cell-Type Specific Functions of Giantin
Giantin is expressed ubiquitously (Fagerberg et al., 2014), and
is widely used as a Golgi marker protein. Giantin knock-out
or mutant animal models have revealed the cell-type specific
function of Giantin (Katayama et al., 2011, 2018; Lan et al., 2016;
Bergen et al., 2017; McGee et al., 2017; Stevenson et al., 2017).
Moreover, Giantin gene mutations and pathogenic changes in
Giantin levels have been reported in various diseases, including
sickle cell disease (Alsultan et al., 2018; Amlie-Lefond et al., 2018),
bipolar disorder (Kerner et al., 2013), hepatocellular carcinoma
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(Choi et al., 2017), leukemia (Troadec et al., 2017), pulmonary
disease (Raparelli et al., 2018), and post-alcohol recovery (Casey
et al., 2018). These various phenotypes might be caused by
the expression of Giantin binding partners, including GCP60
(Sohda et al., 2001), RCAN2 (Stevenson et al., 2018), PRMT5
(Sohail et al., 2015), PLK3 (Ruan et al., 2004), Rab6, p115, and
Rab1 (Beard et al., 2005). In the present study, we noticed
that immunofluorescence of GCP60 around the Golgi was less
distinct after the loss of Giantin (data not shown). Therefore,
GCP60 may function together with Giantin in the independence
of Golgi stacks.
CONCLUSION AND PERSPECTIVES
Our study found that Golgi stacks and cisternae changed their
structure following the loss of Giantin, which may correlate
with our previous finding of the alteration of glycosylation
patterns of cell surface proteins. This is reasonable considering
that glycosylation is a series of chemical reactions and that
Golgi stacks and cisternae are reaction vessels. In other
words, structural changes to reaction vessels by the lateral
linking of Golgi cisternae may alter temporal and local
concentrations of enzymes and substrates for glycosylation
reactions, which may result in changes to surface glycosylation
patterns and secretion.
The correlation between structural changes of the Golgi
and glycosylation patterns was previously explained as a
result of ’sorting zones’ in the Golgi (Yano et al., 2005) in
which each zone has a unique role in providing glycosylation
and sorting. For example, one zone is responsible for
making glycosaminoglycans, and the others are responsible
for protein N-glycosylation or GPI-anchoring. It could be
speculated that these sorting zones are lost following Giantin
knockdown, leading to changes in surface glycosylation patterns.
Future studies using recent technologies including super-
resolution microscopy (Tie et al., 2018), cryo-focused ion
beam scanning electron microscopy (FIB-SEM) with membrane
segmentation by deep learning, and other new methods
(Ranftler et al., 2017; Gorelick et al., 2019) will help dissect the
structural changes associated with Golgi stacks and cisternae
and sorting zones.
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